209 related articles for article (PubMed ID: 16258428)
1. Reirradiation: exploring new territory in the therapy of recurrent head and neck cancer.
Langer C; Damsker J; Ridge A
Clin Adv Hematol Oncol; 2003 Jul; 1(7):424-9, 440. PubMed ID: 16258428
[TBL] [Abstract][Full Text] [Related]
2. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K
J Clin Oncol; 2007 Oct; 25(30):4800-5. PubMed ID: 17947728
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
Cohen EE; Rosine D; Haraf DJ; Loh E; Shen L; Lusinchi A; Vokes EE; Bourhis J
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):678-84. PubMed ID: 17293229
[TBL] [Abstract][Full Text] [Related]
5. Reirradiation in squamous cell head and neck cancer: recent developments and future directions.
Langendijk JA; Bourhis J
Curr Opin Oncol; 2007 May; 19(3):202-9. PubMed ID: 17414637
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-based chemotherapy for recurrent and/or metastatic head and neck squamous cell carcinoma: current and future directions.
Shin DM; Lippman SM
Semin Oncol; 1999 Feb; 26(1 Suppl 2):100-5. PubMed ID: 10190789
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation.
Krstevska V; Tolevska C; Zafirova-Ivanova B; Stojkovski I; Crvenkova S
J BUON; 2008; 13(3):369-76. PubMed ID: 18979552
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
Budach W; Hehr T; Budach V; Belka C; Dietz K
BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for head and neck cancer.
Tannock IF
J Otolaryngol; 1984 Apr; 13(2):99-104. PubMed ID: 6202878
[TBL] [Abstract][Full Text] [Related]
10. The expanding role of systemic therapy in head and neck cancer.
Cohen EE; Lingen MW; Vokes EE
J Clin Oncol; 2004 May; 22(9):1743-52. PubMed ID: 15117998
[TBL] [Abstract][Full Text] [Related]
11. Organ and function preservation: the role of surgery as the optimal primary modality or as salvage after chemoradiation failure.
Scher RL; Esclamado RM
Semin Radiat Oncol; 2009 Jan; 19(1):17-23. PubMed ID: 19028341
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival following salvage reirradiation with concurrent chemotherapy for recurrent head and neck cancer.
Watkins JM; Stuart RK; Davis BK; Day TA; Chaudharry UB; Sharma AK
J S C Med Assoc; 2008 Feb; 104(2):36-9. PubMed ID: 18396601
[No Abstract] [Full Text] [Related]
13. Integrating novel agents into the curative treatment of head and neck cancer.
Haddad R; Allen A; Wirth L; Tishler R; Posner M
Expert Rev Anticancer Ther; 2006 Feb; 6(2):157-9. PubMed ID: 16445367
[No Abstract] [Full Text] [Related]
14. Chemotherapy for recurrent and metastatic head and neck cancer.
Pinto HA; Jacobs C
Hematol Oncol Clin North Am; 1991 Aug; 5(4):667-86. PubMed ID: 1890059
[TBL] [Abstract][Full Text] [Related]
15. Postoperative reirradiation for mucosal head and neck squamous cell carcinomas.
Iseli TA; Iseli CE; Rosenthal EL; Caudell JJ; Spencer SA; Magnuson JS; Smith AN; Carroll WR
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1158-64. PubMed ID: 19917931
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival after salvage reirradiation of head and neck cancer.
Tanvetyanon T; Padhya T; McCaffrey J; Zhu W; Boulware D; Deconti R; Trotti A
J Clin Oncol; 2009 Apr; 27(12):1983-91. PubMed ID: 19289616
[TBL] [Abstract][Full Text] [Related]
17. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA
J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425
[TBL] [Abstract][Full Text] [Related]
18. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?
Wong SJ; Machtay M; Li Y
J Clin Oncol; 2006 Jun; 24(17):2653-8. PubMed ID: 16763279
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.
Janot F; de Raucourt D; Benhamou E; Ferron C; Dolivet G; Bensadoun RJ; Hamoir M; Géry B; Julieron M; Castaing M; Bardet E; Grégoire V; Bourhis J
J Clin Oncol; 2008 Dec; 26(34):5518-23. PubMed ID: 18936479
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
Milano MT; Vokes EE; Kao J; Jackson W; List MA; Stenson KM; Witt ME; Dekker A; MacCracken E; Garofalo MC; Chmura SJ; Weichselbaum RR; Haraf DJ
Int J Oncol; 2006 May; 28(5):1141-51. PubMed ID: 16596230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
